Summary: Human hepatocellular carcinoma cell lines cultured in a monolayer show negligible activities of drug-metabolizing enzymes such as cytochrome P450s (CYPs) and UDP-glucuronosyltransferases (UGTs). Here, we show that culture of human hepatocellular carcinoma FLC-4 cells on 24-well plates arrayed with uniform micro-sized compartments on the bottom of the plates (micro-space cell culture plates) resulted in increased expression of drug-metabolizing enzymes (CYP1A2, CYP2C9, CYP3A4, UGT1A1, etc.) and nuclear receptors (pregnane X receptor, constitutive androstane receptor, etc.). When cells were treated with a typical CYP3A substrate (triazolam), CYP2C9 substrate (diclofenac) or UGT1A1 substrate (SN-38), large amounts of their metabolites were detected in the medium of cells cultured on micro-space cell culture plates. The formation of metabolites from triazolam, diclofenac and SN-38 was strongly inhibited by cotreatment with a CYP3A inhibitor (ketoconazole), CYP2C9 inhibitor (sulfaphenazole) and UGT1A1 inhibitor (ketoconazole), respectively. On the other hand, formation of metabolites was not observed in the medium of cells cultured in a monolayer. Finally, the cytotoxic effect of aflatoxin B1 was more potent in cells cultured on micro-space cell culture plates than in cells cultured in a monolayer. The results suggest that FLC-4 cells cultured on micro-space cell culture plates are useful for studying drug metabolism and druginduced hepatotoxicity.
Introduction
Human primary hepatocytes are widely used in in vitro experiments for drug metabolism and toxicity, 1,2¥ but their usage is limited by several factors including low availability of fresh liver samples, failure in continuous culture and interindividual differences between donors. On the other hand, human hepatocellular carcinoma cell lines, such as HepG2 and Huh7 cells, show certain reproducibility of experimental data in long-term experiments because of a stable phenotype and an unlimited lifespan. Therefore, these cell lines have been widely used in in vitro experiments such as cell-based reporter gene assays and toxicological studies.
3,4¥ However, the mRNA expression levels and catalytic activities of drug-metabolizing enzymes such as cytochrome P450 ¤CYP¥ in human hepatocellular carcinoma-derived cells are much lower than those in human primary hepatocytes.
5, 6¥ The expression levels of the other drug-metabolizing enzymes and drug transporters in those cell lines are also lower than those in human primary hepatocytes.
7®9¥
Some cell lines have been established from Japanese hepatocellular carcinoma patients. 10¥ For example, cell lines named FLC-4, FLC-5 and FLC-7 express CYP3A4 as well as CYP1A1, CYP1B1 and CYP2E1, which are important drugmetabolizing enzymes responsible for hepatic metabolism of more than half of the therapeutic drugs on the market. Although the expression levels of CYP3A4 in FLC-5 cells were low in monolayer culture, they were increased by three-dimensional culture in a radial-flow bioreactor. 11¥ This finding suggests that FLC cells lines have a potency to express functional drug-metabolizing enzymes when cells are cultured in suitable conditions.
Recently, 24-well culture plates arrayed with uniform micro-sized compartments on the bottom of the plates ¤micro-space cell culture plates¥ have been developed. Cultured cells show a three-dimensional form on the microspace cell culture plates.
12,13¥ However, it remains unknown whether this culture system can increase the expression levels of drug-metabolizing enzymes and drug transporters in these FLC cell lines.
In this study, we compared mRNA expression levels and catalytic activities of drug-metabolizing enzymes in FLC-4 cells cultured on micro-space culture plates with those in cells cultured on conventional plates. We report herein that FLC-4 cells cultured on micro-space culture plates show increased expression levels of various drug-metabolizing enzymes, increased catalytic activities for CYP3A4, CYP2C9 and UGT1A1, and possibilities for use in the CYP3A4-mediated cytotoxicity assay.
Materials and Methods
Materials: Aflatoxin B1, glutaraldehyde, phenobarbital sodium, triazolam ¤TRZ¥ and UDP-glucuronic acid trisodium were purchased from Wako Pure Chemicals ¤Osaka, Japan¥, 7-ethyl-10-hydroxycamptothecin ¤SN-38¥ and ¤S¥-¤¦¥-camptothecin ¤CPT¥ were from Tokyo Kasei ¤Tokyo, Japan¥ and ketoconazole was from Sigma-Aldrich ¤St. Louis, MO¥. AE-Hydroxy TRZ ¤AE-OH TRZ¥ and 4-hydroxy TRZ ¤4-OH TRZ¥ were supplied by Nihon Upjohn ¤Tokyo, Japan¥, oxazepam was supplied by F. Hoffmann-La Roche ¤Basel, Switzerland¥, diclofenac ¤DIC¥ and 4$-hydroxydiclofenac ¤4$-OH DIC¥ were supplied by Nihon Ciba-Geigy ¤Tokyo, Japan¥, zaltoprofen was supplied by Zeria Pharmaceutical ¤Tokyo, Japan¥, SN-38 glucuronide ¤SN-38G¥ was supplied by Yakult ¤Tokyo, Japan¥ and sulfaphenazole was supplied by Meiji Yakuhin ¤Tokyo, Japan¥. All other reagents were of the highest grade commercially available.
Cell culture: The human hepatocellular carcinoma cell line FLC-4 was cultured in Dulbeccoös modified Eagleös/ Hamös F12 medium ¤Invitrogen, Carlsbad, CA¥ with 5% CO 2 at 37ôC. The medium was supplemented with 10% ¤v/v¥ heat-inactivated fetal bovine serum ¤BenchMark, Woodland, CA¥ and with 100 units/mL penicillin G and 100 µg/mL streptomycin ¤Invitrogen¥. FLC-4 cells were seeded at a density of 7.5 ' 10 4 or 8.0 ' 10 5 cells/well on conventional 24-well plates ¤Griner Japan, Tokyo, Japan¥ or seeded at a density of 8.0 ' 10 5 cells/well on micro-space cell culture plates with 200-µm-long ' 200-µm-wide ' 100-µm-deep square compartments on the culture well surface ¤Elplasia SQ 200 100 24, Kuraray, Tokyo, Japan, see Fig. 1¥ . The micro-space cell culture plates were coated with a mixture of 0.01% poly-L-lysine and 0.01% 2-methacryloyloxyethyl phosphorylcholine polymer ¤10/90, v/v¥. The medium was changed every 2 or 3 days.
Human liver tissues: Human liver tissues ¤n © 4¥ were supplied by the National Disease Research Interchange ¤Philadelphia, PA¥ through the HAB Research Organization ¤Tokyo, Japan¥. The use of human liver samples in this study was approved by the Ethics Committee of Chiba University.
Gene expression analysis by a DNA microarray: Expression of drug metabolism-related and transportrelated genes was analyzed by using a DNA microarray ¤GeneSQUARE Multiple Assay DNA Microarray Drug Metabolism Gene Expression For Human, Kurabo Industries Ltd., Osaka, Japan¥ on which 109 genes are spotted ¤23 CYPs, 45 transferases, 30 transporters, 11 nuclear receptors, 6 housekeeping genes and 4 negative control genes¥. Total RNA was isolated using a FastPure RNA kit ¤TaKaRa, Shiga, Japan¥ according to the manufacturerös protocol. Fluorescence ¤Alexa Fluor 555¥-labeled cDNA probes were prepared from 10 µg of total RNA using a direct labeling kit ¤Kurabo¥. Fluorescence-labeled cDNA was added to the hybridization mixture. After denaturing at 95ôC for 2 min, it was applied onto a block of the DNA microarray plate and incubated at 65ôC for 16 h. The signals of the targets were analyzed by using a GenePix 4200A ¤Axon Instruments, Union City, CA¥ at a wavelength of 532 nm, PMT gain of 300 and scan power of 100. Signal values of the surrounding background were subtracted from those of the target gene and glyceraldehyde 3-phosphate dehydrogenase ¤GAPDH¥ as an internal control, and signal intensities of target genes were normalized against those of the internal control.
Gene expression analysis by real-time PCR: Isolated total RNA was treated with RNase-free DNase I ¤TaKaRa¥ to remove contaminating genomic DNA. cDNA was synthesized by reverse transcription with random hexamers using a High Capacity cDNA Reverse Transcription kit ¤Applied Biosystems, Foster City, CA¥. To measure mRNA levels of genes, cDNAs prepared from total RNA were subjected to quantitative real-time PCR with the ABI Prism 7000 Sequence Detection system ¤Applied Biosystems¥. The mRNA levels were determined using TaqMan Gene Expression Assays designed for CYP1A2 ¤Hs00167927ðm1¥, CYP2B6 ¤Hs03044634ðm1¥, CYP2C9 ¤Hs00426397ðm1¥, CYP3A4 ¤Hs00604506ðm1¥, CYP7A1 ¤Hs00167982ðm1¥, UGT1A1 ¤Hs02511055ðs1¥, hepatocyte nuclear factor 4AE ¤HNF4AE, Hs00230853ðm1¥, CCAATenhancer binding protein AE ¤C/EBPAE, Hs00269942ðs1¥, pregnane X receptor ¤PXR, Hs00243666ðm1¥, constitutive androstane receptor ¤CAR, Hs00231959ðm1¥, albumin ¤Hs00609411ðm1¥ and glucose-6-phosphatase ¤G6P, Hs00292720ðm1¥. The mRNA levels were normalized against GAPDH determined by Pre-Developed TaqMan Assay Reagents.
Determination of catalytic activity: DIC, TRZ and SN-38 were used as specific substrates for CYP2C9, CYP3A and UGT1A1, respectively. DIC metabolite ¤4$-OH DIC¥, TRZ metabolites ¤AE-OH TRZ and 4-OH TRZ¥, and SN-38 metabolite ¤SN-38G¥ secreted in the culture medium were determined by high-pressure liquid chromatography ¤HPLC¥. Cells were treated with 20 µM DIC, 50 µM TRZ or 10 µM SN-38 for 24 h. Stock solutions of DIC, TRZ and SN-38 were prepared in dimethyl sulfoxide ¤DMSO¥, and the final concentration of the solvent was 0.25% ¤v/v¥. The control culture received a vehicle ¤0.25% DMSO¥ alone. Culture medium ¤150 µL¥ treated with DIC or TRZ was mixed with 600 µL of acetonitrile, and 25 µL of zaltoprofen ¤5 µg/mL in methanol¥ or 50 µL of oxazepam ¤0.2 µg/mL in methanol¥ was added as an internal standard for DIC or TRZ, respectively. After centrifugation ¤12,000 ' g, 15 min¥, the soluble layer was evaporated. The residue was reconstituted with 160 µL of mobile phase, and an aliquot of 100 µL was subjected to HPLC analysis using a Hitachi HPLC system consisting of an L-7100 pump, an L-7400 UV detector, an L-7200 autosampler, a D-7500 integrator, and an 821-FP intelligent spectrofluorometer ¤Jasco, Tokyo, Japan¥ as described elsewhere. 14¥ Briefly, the mobile phase for DIC consisted of 10 mM potassium phosphate buffer ¤pH 7.4¥/acetonitrile ¤70/30, v/v¥ with a flow rate of 0.8 mL/min. An L-column ODS ¤4.6 mm ' 250 mm, 5 µm, Chemicals Evaluation and Research Institute, Tokyo, Japan¥ was used. The eluent was monitored at 282 nm. The mobile phase for TRZ consisted of 10 mM potassium phosphate buffer ¤pH 7.4¥/acetonitrile/methanol ¤60/30/10, v/v/v¥ with a flow rate of 0.8 mL/min. A CAPCELL PAK C18 UG120 column ¤4.6 mm ' 250 mm, 5 µm, Shiseido, Tokyo, Japan¥ was used. The eluent was monitored at 220 nm. Culture medium ¤40 µL¥ treated with SN-38 was mixed with 10 µL of 10% perchloric acid, and 10 µL of CPT ¤0.1 µg/mL in DMSO¥ was added as an internal standard. After centrifugation ¤12,000 ' g, 15 min¥, the soluble layer ¤10 µL¥ was diluted with 150 µL of mobile phase and 100 µL was analyzed. The mobile phase for the determination of SN-38 consisted of 50 mM monopotassium phosphate ¤pH 2.5¥ containing 3 mM sodium 1-octane sulfonate/acetonitrile/methanol ¤72:22:6, v/v/v¥ with a flow rate of 1.0 mL/min. TSK gel ODS-100Z ¤4.6 mm ' 250 mm, 5 µm, Tosoh, Tokyo, Japan¥ was used. The eluent was monitored fluorometrically ¤excitation: 370 nm; emission 425 nm¥.
Assessment of CYP3A4-dependent cytotoxicity: Cells that had been cultured on the micro-space cell culture plates for 10 days or on the conventional 24-well plates for 2 or 10 days were treated with 0, 5, 10, 20 or 40 µM of aflatoxin B1 for 24 h. The cytotoxic effect was determined by measuring lactate dehydrogenase ¤LDH¥ leakage according to the manufacturerös protocol ¤LDH Cytotoxicity Detection Kit, Roche Applied Science, Basel, Switzerland¥ and was expressed relative to the maximum LDH activity determined for lysed cells ¤100% cytotoxicity¥. The absorbance at 490 nm was determined with an ARVO-SX multilabel counter ¤Perkin Elmer Japan, Yokohama, Japan¥. To confirm the involvement of CYP3A4 in the aflatoxin B1-induced cytotoxicity, cells treated with 40 µM of aflatoxin B1 were co-incubated with 1, 3 or 5 µM of ketoconazole. Aflatoxin B1 was prepared in DMSO, and the final concentration of the solvent was 0.1% ¤v/v¥.
Statistical analysis: Data are presented as means + S.D. Statistical analyses were performed by using Statcel ¤OMS, Tokyo, Japan¥. Comparison of multiple groups was made by ANOVA followed by post-hoc test of Scheffeös F. p g 0.05 was considered statistically significant.
Results
Morphology of FLC-4 cells grown on micro-space cell culture plates: As shown in Figure 2 , FLC-4 cells on micro-space cell culture plates began conglomerating from day 3 of culture and had formed spheroidal aggregates at day 14 of culture in each compartment ¤Figs. 2A®2D¥. Under an electron microscope, the cells were spherical, indicating that 3-dimensional culture had been obtained ¤Fig. 2E¥. When FLC-4 cells ¤7.5 ' 10 4 cells/well¥ were cultured on conventional 24-well plates for 2 days, the control cells grew in a monolayer ¤Fig. 2F¥. As a preliminary experiment, we seeded cells at various densities on micro-space cell culture plates. We found that a density of 8.0 ' 10 5 cells/well was most suitable for efficient spheroid formation. Thus, FLC-4 cells ¤8.0 ' 10 5 cells/well¥ were also cultured on conventional 24-well plates for 14 days. As shown in Figure 2G , the cells were grown to confluence.
Expression of hepatic differentiation markers: Because of the characteristic morphology of FLC-4 cells grown on micro-space cell culture plates, we assumed that the cells grown on micro-space cell culture plates might have enhanced hepatocyte-specific functions in comparison to the control cells grown in a monolayer. Initially, we evaluated the mRNA expression levels of hepatic differentiation markers, albumin, CYP7A1 and G6P. As shown in Figure 3 , the relative mRNA expression levels of albumin, CYP7A1 and G6P in cells grown on micro-space cell culture plates increased with culture time. Remarkably increased mRNA expression levels of albumin and CYP7A1 were observed from day 3 to day 14 after seeding cells ¤Figs. 3A and 3B¥. The relative mRNA expression level of G6P also increased during the same period ¤Fig. 3C¥.
Expression of drug-metabolizing enzymes, transporters and transcription factors: Since FLC-4 cells grown on the micro-space cell culture plates showed dramatically high expression levels of hepatic differentiation markers, we studied comprehensive expression of drug metabolism-related and transport-related genes in cells by using a DNA microarray ¤Table 1 and Figs. S1 and S2¥. For many of the genes studied, the relative levels of gene expression in cells grown on the micro-space cell culture plates were higher than those in the control cells grown in a monolayer. Most of the CYPs and UGTs were highly expressed in cells grown on the micro-space cell culture plates.
Expression of CYP isoforms, UGT1A1 and their regulatory factors: The mRNA levels of four drugmetabolizing enzymes ¤CYP1A2, CYP2C9, CYP3A4 and UGT1A1¥ and four transcription factors ¤HNF4AE, C/EBPAE, PXR and CAR¥ regulating the expression of these genes were also quantified by real-time PCR and compared among cells grown on the micro-space cell culture plates, control cells grown in a monolayer and confluent cells. As shown in Figure 4 , the mRNA expression levels of CYP1A2, CYP2C9, CYP3A4 and UGT1A1 in cells grown on the micro-space cell culture plates were much higher than those in control cells. Compared with the control cells, confluent cells showed higher expression levels of these genes, but the expression levels were lower than those in cells grown on the micro-space cell culture plates. The expression levels of HNF4AE, C/EBPAE, PXR and CAR were also much higher in cells grown on the micro-space cell culture plates than those in both the control cells and confluent cells ¤Fig. 5¥.
Increased catalytic activities for CYP2C9, CYP3A4 and UGT1A1 in FLC-4 cells cultured on micro-space cell culture plates:
Next, we investigated whether CYP2C9, CYP3A4 and UGT1A1 expressed in FLC-4 cells grown on micro-space cell culture plates had sufficient enzymatic functions to metabolize specific substrates, DIC, TRZ and SN-38, respectively. Formation of the metabolites in cells grown on micro-space cell culture plates was compared with that in control cells grown in a monolayer and that in confluent cells. Although no metabolite of DIC, TRZ 5 cells/well on microspace cell culture plates and cultured for 15 min (A), 3 days (B), 7 days (C) and 14 days (D and E). As a control, FLC-4 cells were seeded at a density of 7.5 × 10 4 cells/well on conventional cell culture plates and cultured for 2 days (F). Cells seeded at a density of 8.0 × 10 5 cells/well were cultured on conventional plates for 14 days (G). Morphology was observed by microscopy (A-D, F and G) or electron microscopy (E). For electron microscopy, the cells were fixed with 2.5% glutaraldehyde.
Fig. 3. Levels of mRNA expression of hepatic differentiation marker genes albumin (A), CYP7A1 (B) and G6P (C) in FLC-4 cells
Levels of mRNAs were determined by real-time PCR. The control cells (Ctrl) were seeded at a density of 7.5 × 10 4 cells/well on conventional cell culture plates and cultured for 2 days. Cells seeded at a density of 8.0 × 10 5 cells/well on micro-space cell culture plates (Micro-space) were cultured for 3, 7 and 14 days. The expression levels of albumin, CYP7A1 and G6P were normalized by those of GAPDH. Data are expressed as fold change compared to the control cells and shown as means + S.D. of three independent experiments, each performed in duplicate. N.D., not detected. ***p g 0.001 compared with the value in control cells. Genes shown in parenthesis were not detected in the pooled human liver tissues. SULT, sulfotransferase; GST, glutathione S-transferase; BAAT, bile acid-CoA:amino acid N-acyltransferase; NAT, N-acetyltransferase; ABC, ATP-binding cassette; AHR, aryl hydrocarbon receptor; ARNT, AhR nuclear translocator; FXR, farnesoid X receptor; PPAR, peroxisome proliferator-activated receptor; RXR, retinoid X receptor. Cells were cultured on micro-space cell culture plates for 14 days ¤Micro-space¥ and on conventional cell culture plates for 2 days ¤Ctrl¥ or 14 days ¤Conf¥.
Fig. 4. Levels of mRNA expression of drug-metabolizing enzymes CYP1A2 (A), CYP2C9 (B), CYP3A4 (C) and UGT1A1 (D) in FLC-4 cells
Levels of mRNAs were determined by real-time PCR. Cells were seeded at a density of 8.0 × 10 5 cells/well on micro-space cell culture plates and cultured for 14 days (Micro-space). The control cells (Ctrl) were seeded at a density of 7.5 × 10 4 cells/well on conventional cell culture plates and cultured for 2 days. Cells cultured on conventional plates for 14 days were grown to confluence after seeding at a density of 8.0 × 10 5 cells/well (Conf ). The expression levels of CYP1A2, CYP2C9, CYP3A4 and UGT1A1 were normalized by those of GAPDH. Data are expressed as fold change compared to the control cells and shown as means + S.D. of three independent experiments, each performed in duplicate. **p g 0.01 and ***p g 0.001 compared with the value in control cells.
† † † p g 0.001 compared with the value in confluent cells. or SN-38 was detected in the culture medium of control cells, small amounts of metabolites were detected in the culture medium of the confluent cells ¤Fig. 6¥. In cells grown on micro-space cell culture plates, the formation levels of metabolites were remarkably high, being consistent with the mRNA expression levels of CYP2C9, CYP3A4 and UGT1A1 in these cells ¤Fig. 4¥. In addition, the formation of metabolites in the cells was strongly inhibited by cotreatment by inhibitors of CYP2C9, CYP3A4 and UGT1A1, respectively.
Cytotoxicity induced by aflatoxin B1: To evaluate whether FLC-4 cells grown on micro-space cell culture plates could be used for studying CYP3A4-mediated toxicity, the cells were treated with aflatoxin B1, a wellknown toxin activated by CYP3A4. 15¥ In the cells grown on micro-space cell culture plates, cytotoxic effects of aflatoxin B1 increased in a dose-dependent manner ¤Fig. 7A¥. Aflatoxin B1-induced toxicity was also detected in confluent cells, though the toxicity was modest. In contrast, no effect was observed in control cells grown in a monolayer. As shown in Figure 7B , aflatoxin B1-induced toxicity in cells cultured on micro-space cell culture plates was dose-dependently prevented by ketoconazole treatment.
Discussion
The use of human hepatocellular carcinoma cell lines is limited in studies on drug metabolism and toxicity. One of the major reasons is their negligible activity of drugmetabolizing enzymes when cultured in a monolayer. 6¥ In this study, we showed that culture of human hepatocellular carcinoma FLC-4 cells on micro-space cell culture plates resulted in increased functional expression of various drugmetabolizing enzymes.
In the present study, the mRNA expression levels of CYP1A2, CYP2C9, CYP3A4 and UGT1A1 in confluent cells were higher than those in control cells, whereas cells grown on micro-space cell culture plates showed even higher mRNA expression levels ¤Fig. 4¥. The corresponding catalytic activities were also increased by culture using micro-space cell culture plates ¤Fig. 6¥. The activities were inhibited by treatment with an inhibitor for CYP3A4, CYP2C9 or UGT1A1 ¤Fig. 6¥. These results suggest that FLC-4 cells Increased Expression of Drug-metabolizing Enzymesgrown on micro-space cell culture plates expressed functional CYP3A4, CYP2C9 and UGT1A1 proteins.
FLC-4 cells grown on micro-space cell culture plates showed significantly high levels of cytotoxicity induced by aflatoxin B1 ¤Fig. 7¥. The cytotoxic effects were prevented by treatment with a CYP3A4 inhibitor. These results suggest that CYP3A4-mediated cytotoxic effects of aflatoxin B1 can be detected in FLC-4 cells grown on micro-space cell culture plates. This culture system might be useful for studying drug-induced hepatotoxicity, at least for metabolic activation via CYP3A4.
Not only CYP3A4 mRNA but also CYP3A5 mRNA was increased by culture on micro-space cell culture plates ¤Table 1¥. CYP3A5 is polymorphically expressed in subjects who carry the CYP3A5*1 allele. 16¥ Inheritance of two copies of a variant allele ¤CYP3A5*3, CYP3A5*5 or CYP3A5*6¥ accounts for a markedly reduced expression of CYP3A5 protein as a result of improper mRNA splicing and reduced translation of a functional protein. 16¥ Since FLC-4 cells carry the CYP3A5*3 allele but not CYP3A5*1 allele, the increase in CYP3A5 mRNA expression observed in cells grown on micro-space cell culture plates is of no effect on the active CYP3A5 level. Therefore, catalytic activity of CYP3A detected in FLC-4 cells grown on micro-space cell culture plates appears to be mainly mediated by CYP3A4.
In this study, SN-38 was used as a probe of UGT1A1. However, UGT1A9 is also involved in the formation of SN-38G, although intrinsic clearance ¤V max /K m ¥ for the formation of SN-38G of UGT1A9 is about 10-fold lower than that of UGT1A1. 17¥ Since UGT1A9 mRNA was increased by culture in micro-space cell culture plates ¤Table 1¥, we cannot exclude the possibility that UGT1A9 contributed to the formation of SN-38G in the cells.
It has been reported that HepG2 cells grown on a microspace cell culture system displayed 7-fold higher expression levels of CYP3A4 mRNA than did those grown on a monolayer culture system. 13¥ However, the catalytic activity of CYP3A4 was not investigated in that study. On the other hand, FLC-4 cells grown on the micro-space cell culture system showed much higher catalytic activity of CYP3A4 than that of cells grown on the monolayer culture system ¤Fig. 6¥. The levels of CYP3A4 mRNA in cells grown on the micro-space cell culture system were also dramatically higher than those in cells grown on the monolayer culture system ¤h5,000 fold, Fig. 4¥ . Therefore, this phenotypical change that occurs by culture using the micro-space cell culture system is not common for all hepatocellular carcinoma cell lines.
When human hepatocellular carcinoma Huh7 cells and B16A2 cells are grown to confluence, proliferation is inhibited, resulting in a dense layer of cells. 18,19¥ These cells show more hepatocyte-like characteristics as illustrated by higher expression levels of drug-metabolizing enzymes, transcription factors and liver-specific genes such as albumin and G6P. In this study, FLC-4 cells cultured on conventional plates for 10 or 14 days were also grown to confluence. The confluent cells showed more hepatocyte-like characteristics compared with FLC-4 cells cultured in a monolayer ¤Figs. 3®5¥. However, compared with confluent FLC-4 cells on conventional plates, FLC-4 cells on micro-space cell culture plates showed much higher expression levels of drug-metabolizing enzymes, transcription factors and liver-specific genes such as albumin, G6P and CYP7A1 ¤Figs. 3®5¥. In the case of FLC-4 cells, cells grown on micro-space cell culture plates appear to be superior to confluent cells on conventional plates as an in vitro system for prediction of drug metabolism.
When FLC-4 cells were cultured on micro-space cell culture plates, cell proliferation was inhibited and cells formed spheroidal aggregates ¤Fig. 2¥. The cells grown on micro-space cell culture plates showed high expression levels of liver-specific genes ¤Figs. 3®5¥. These results are consistent with the findings in rat primary hepatocytes cultured as spheroids, suggesting that the cell morphological change and cell-cell interaction caused by the spheroid formation are key factors promoting the expression of liverspecific functions. 20¥ However, the molecular mechanism has not been fully clarified. Similar to FLC-4 cells grown on micro-space cell culture plates, rat primary hepatocytes cultured as spheroids showed higher expression levels of C/EBPAE compared with those in a monolayer culture. Since C/EBPAE can regulate the expression of cyclin-dependent protein kinase inhibitors, p21 and p27, it may be responsible for the prevention of FLC-4 cell proliferation. In addition, C/EBPAE has been reported to up-regulate the expression of genes including albumin and some CYP isoforms.
5,21¥
Therefore, elevated expression of C/EBPAE may contribute to the increased liver functions in FLC-4 cells, although other transcription factors such as HNF4AE contribute to the expression of liver-specific functions. Further studies are needed to clarify the molecular mechanism of spheroid formation and the expression of liver-specific functions in FLC-4 cells grown on micro-space cell culture plates.
In summary, FLC-4 cells grown on micro-space cell culture plates showed high expression levels of various drugmetabolizing enzymes and some transcription factors. FLC-4 cells show certain reproducibility in long-term experiments because of a stable phenotype and an unlimited lifespan. In addition, cells were easily grown as a three-dimensional form by culture on micro-space cell culture plates. Therefore, the results suggest that human hepatocellular carcinoma FLC-4 cells grown on micro-space cell culture plates are useful for studying drug metabolism and drug-induced hepatotoxicity.
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